Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2115162Generated: October 29, 2026

Ethanol → 6-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)cyclopropyl)-3-pyridinecarboxylic acid

https://huagongshe.com/reaction/2115162

Reaction equation

Participants

RoleNameHCIDCharge
ReactantEthanolHCID 702—
ReactantBardoxoloneHCID 400010—
ReactantBardoxolone MethylHCID 400769—
ReactantRetinoic AcidHCID 444795—
SolventDimethyl SulfoxideHCID 679—
Product6-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)cyclopropyl)-3-pyridinecarboxylic acidHCID 3922—

Reaction Steps

Reagents. Stock solutions of CDDO and/or CDDO-Me at 10 mM in DMSO were stored at −20° C. Working solutions were prepared in DMSO and added directly to culture medium. ATRA was purchased from Sigma Chemical Co. (St. Louis, Mo.) and kept in 100% ethanol solution at −20° C. RXR-specific ligand LG-100268 was kindly provided by Dr. Richard Heyman. Caspase-3 inhibitor Z-DEVD-fmk and bongkrekic acid (BA) were obtained from Calbiochem (La Jolla, Calif.). Cyclosporin A (CyA) was purchased from Sandoz. Fas-signaling antibody CH11 and Fas-blocking antibody ZB4 were obtained from Immunotech (Miami, Fla.).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07435755B2
Source datasetuspto-grants-2008_10
ORD IDord-b45adcc08b6c4c37a67d8aa3725ea976
Source noteuspto-grants-2008_10